Skip to content

Anika Therapeutics ANIK FX Effect on Cash

FX Effect on Cash at other companies

Stryker logo
StrykerSYK
-$19M-195%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$1.1M-84.3%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$38K
Bioventus logo
BioventusBVS
-$608K-241%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
-$2K0.0%
Globus Medical logo
Globus MedicalGMED
-$3.09M-187%

Other financials

Income statement

See full
Revenue$29.6M+13.2%
Net income-$5.1M-3.8%

Balance sheet

See full
Cash & equivalents$41.0M-23.1%
Total debt$25.7M+1.2%
Total equity$133.9M-9.8%
Total assets$179.4M-5.9%

Cash flow

See full
Operating cash flow-$4.8M-3,628%
CapEx$1.4M-49.3%
Free cash flow-$6.3M-112%

Valuation

See full
Market cap$204.37M+31.6%
Enterprise value$189.09M+48.7%
P/S1.8×+0.1×

Profitability

See full
Net margin-9.8%-4.4pp
FCF margin0.9%

Returns & leverage

See full
Return on equity-8%-3.4pp
Debt / equity0.2×0.0×
Current ratio4.5×-1.3×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Anika Therapeutics's FX effect on cash?
Anika Therapeutics (ANIK) reported FX effect on cash of -$29K in Q1 2026.
How has Anika Therapeutics's FX effect on cash changed year-over-year?
Anika Therapeutics's FX effect on cash decreased by 126.9% year-over-year, from $108K to -$29K.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.